125 related articles for article (PubMed ID: 17590405)
1. Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing.
Tatsis N; Lin SW; Harris-McCoy K; Garber DA; Feinberg MB; Ertl HC
Virology; 2007 Oct; 367(1):156-67. PubMed ID: 17590405
[TBL] [Abstract][Full Text] [Related]
2. The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.
Peters C; Peng X; Douven D; Pan ZK; Paterson Y
J Immunol; 2003 May; 170(10):5176-87. PubMed ID: 12734365
[TBL] [Abstract][Full Text] [Related]
3. Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.
Pinto AR; Fitzgerald JC; Giles-Davis W; Gao GP; Wilson JM; Ertl HC
J Immunol; 2003 Dec; 171(12):6774-9. PubMed ID: 14662882
[TBL] [Abstract][Full Text] [Related]
4. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M
J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024
[TBL] [Abstract][Full Text] [Related]
5. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
[TBL] [Abstract][Full Text] [Related]
6. Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus.
de Souza AP; Haut LH; Silva R; Ferreira SI; Zanetti CR; Ertl HC; Pinto AR
Vaccine; 2007 Jan; 25(1):109-16. PubMed ID: 16914235
[TBL] [Abstract][Full Text] [Related]
7. Role of novel type I interferon epsilon in viral infection and mucosal immunity.
Xi Y; Day SL; Jackson RJ; Ranasinghe C
Mucosal Immunol; 2012 Nov; 5(6):610-22. PubMed ID: 22617838
[TBL] [Abstract][Full Text] [Related]
8. M cell DNA vaccination for CTL immunity to HIV.
Wang X; Hone DM; Haddad A; Shata MT; Pascual DW
J Immunol; 2003 Nov; 171(9):4717-25. PubMed ID: 14568947
[TBL] [Abstract][Full Text] [Related]
9. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
[TBL] [Abstract][Full Text] [Related]
10. A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice.
Shephard E; Burgers WA; Van Harmelen JH; Monroe JE; Greenhalgh T; Williamson C; Williamson AL
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):207-17. PubMed ID: 18240963
[TBL] [Abstract][Full Text] [Related]
11. Oral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.
Chamcha V; Jones A; Quigley BR; Scott JR; Amara RR
J Immunol; 2015 Nov; 195(10):5025-34. PubMed ID: 26482408
[TBL] [Abstract][Full Text] [Related]
12. Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines.
Pillai VK; Kannanganat S; Penaloza-Macmaster P; Chennareddi L; Robinson HL; Blackwell J; Amara RR
Vaccine; 2011 Jul; 29(33):5399-406. PubMed ID: 21651938
[TBL] [Abstract][Full Text] [Related]
13. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
14. T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load.
Roshorm Y; Cottingham MG; Potash MJ; Volsky DJ; Hanke T
Eur J Immunol; 2012 Dec; 42(12):3243-55. PubMed ID: 22930183
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.
Lin SW; Cun AS; Harris-McCoy K; Ertl HC
Vaccine; 2007 Mar; 25(12):2187-93. PubMed ID: 17229501
[TBL] [Abstract][Full Text] [Related]
16. Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes.
Rayevskaya MV; Frankel FR
J Virol; 2001 Mar; 75(6):2786-91. PubMed ID: 11222702
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.
Gupta S; Janani R; Bin Q; Luciw P; Greer C; Perri S; Legg H; Donnelly J; Barnett S; O'Hagan D; Polo JM; Vajdy M
J Virol; 2005 Jun; 79(11):7135-45. PubMed ID: 15890953
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes.
Reyes-Sandoval A; Fitzgerald JC; Grant R; Roy S; Xiang ZQ; Li Y; Gao GP; Wilson JM; Ertl HC
J Virol; 2004 Jul; 78(14):7392-9. PubMed ID: 15220412
[TBL] [Abstract][Full Text] [Related]
19. Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.
Hopkins R; Bridgeman A; Bourne C; Mbewe-Mvula A; Sadoff JC; Both GW; Joseph J; Fulkerson J; Hanke T
Eur J Immunol; 2011 Dec; 41(12):3542-52. PubMed ID: 21932450
[TBL] [Abstract][Full Text] [Related]
20. Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.
Reyes-Sandoval A; Rollier CS; Milicic A; Bauza K; Cottingham MG; Tang CK; Dicks MD; Wang D; Longley RJ; Wyllie DH; Hill AV
Mol Ther; 2012 Aug; 20(8):1633-47. PubMed ID: 22354374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
